Antiepileptic drugs (AEDs) in pediatric epilepsy
1. Initial Evaluation and Classification:
- Accurate seizure classification is crucial (focal vs. generalized)
- Consider EEG findings
- Age of patient
- Comorbidities
- Access to medications and monitoring
2. First-line Monotherapy Selection:
For Focal Seizures:
- First choices: Oxcarbazepine, Levetiracetam, Carbamazepine
- Alternative: Lamotrigine
- Special considerations:
* Avoid carbamazepine in patients with cardiac conduction issues
* Levetiracetam preferred if liver dysfunction
* Oxcarbazepine may worsen hyponatremia
For Generalized Seizures:
- First choices: Valproate (not in females of childbearing potential), Levetiracetam
- Alternative: Lamotrigine
- Special considerations:
* Avoid valproate in liver disease
* Avoid valproate in mitochondrial disorders
* Consider lamotrigine in mood disorders
For Absence Seizures:
- First choices: Ethosuximide, Valproate
- Avoid: Carbamazepine, Oxcarbazepine, Phenytoin (may worsen absences)
3. When to Add Second Drug:
Consider add-on therapy when:
- Failed adequate trial of first drug at maximum tolerated dose
- Persistent seizures after 6-8 weeks of optimal dose
- Intolerable side effects preventing dose optimization
4. Choice of Second Drug:
For Focal Seizures:
- If on Levetiracetam → Add Oxcarbazepine/Lamotrigine
- If on Oxcarbazepine → Add Levetiracetam/Topiramate
- If on Carbamazepine → Add Levetiracetam/Lamotrigine
For Generalized Seizures:
- If on Valproate → Add Levetiracetam/Lamotrigine
- If on Levetiracetam → Add Valproate/Topiramate
- If on Lamotrigine → Add Levetiracetam/Valproate
5. Special Populations and Considerations:
Liver Disease:
- Prefer: Levetiracetam, Gabapentin, Pregabalin
- Avoid: Valproate, Carbamazepine
Kidney Disease:
- Dose adjustment needed for: Levetiracetam, Gabapentin, Pregabalin
- Prefer: Carbamazepine, Oxcarbazepine
Behavioral/Psychiatric Comorbidity:
- Prefer: Lamotrigine (mood stabilizing)
- Use caution with: Levetiracetam (may worsen behavior)
- Consider: Oxcarbazepine
6. When to Substitute Instead of Add:
Consider substitution when:
- Severe adverse effects to first drug
- Drug interactions making current therapy unsuitable
- Compliance issues due to dosing schedule
- Cost/availability issues
- Teratogenic concerns (e.g., switching from valproate in adolescent females)
7. Monitoring:
Before Starting:
- Baseline CBC, LFTs, electrolytes
- Consider EKG if starting carbamazepine
- Pregnancy test in adolescent females
During Treatment:
- Regular monitoring of drug levels
- CBC and LFTs as needed
- Monitor for specific drug-related adverse effects
- Growth monitoring
- Academic/behavioral monitoring
1. Initial Evaluation and Classification:
- Accurate seizure classification is crucial (focal vs. generalized)
- Consider EEG findings
- Age of patient
- Comorbidities
- Access to medications and monitoring
2. First-line Monotherapy Selection:
For Focal Seizures:
- First choices: Oxcarbazepine, Levetiracetam, Carbamazepine
- Alternative: Lamotrigine
- Special considerations:
* Avoid carbamazepine in patients with cardiac conduction issues
* Levetiracetam preferred if liver dysfunction
* Oxcarbazepine may worsen hyponatremia
For Generalized Seizures:
- First choices: Valproate (not in females of childbearing potential), Levetiracetam
- Alternative: Lamotrigine
- Special considerations:
* Avoid valproate in liver disease
* Avoid valproate in mitochondrial disorders
* Consider lamotrigine in mood disorders
For Absence Seizures:
- First choices: Ethosuximide, Valproate
- Avoid: Carbamazepine, Oxcarbazepine, Phenytoin (may worsen absences)
3. When to Add Second Drug:
Consider add-on therapy when:
- Failed adequate trial of first drug at maximum tolerated dose
- Persistent seizures after 6-8 weeks of optimal dose
- Intolerable side effects preventing dose optimization
4. Choice of Second Drug:
For Focal Seizures:
- If on Levetiracetam → Add Oxcarbazepine/Lamotrigine
- If on Oxcarbazepine → Add Levetiracetam/Topiramate
- If on Carbamazepine → Add Levetiracetam/Lamotrigine
For Generalized Seizures:
- If on Valproate → Add Levetiracetam/Lamotrigine
- If on Levetiracetam → Add Valproate/Topiramate
- If on Lamotrigine → Add Levetiracetam/Valproate
5. Special Populations and Considerations:
Liver Disease:
- Prefer: Levetiracetam, Gabapentin, Pregabalin
- Avoid: Valproate, Carbamazepine
Kidney Disease:
- Dose adjustment needed for: Levetiracetam, Gabapentin, Pregabalin
- Prefer: Carbamazepine, Oxcarbazepine
Behavioral/Psychiatric Comorbidity:
- Prefer: Lamotrigine (mood stabilizing)
- Use caution with: Levetiracetam (may worsen behavior)
- Consider: Oxcarbazepine
6. When to Substitute Instead of Add:
Consider substitution when:
- Severe adverse effects to first drug
- Drug interactions making current therapy unsuitable
- Compliance issues due to dosing schedule
- Cost/availability issues
- Teratogenic concerns (e.g., switching from valproate in adolescent females)
7. Monitoring:
Before Starting:
- Baseline CBC, LFTs, electrolytes
- Consider EKG if starting carbamazepine
- Pregnancy test in adolescent females
During Treatment:
- Regular monitoring of drug levels
- CBC and LFTs as needed
- Monitor for specific drug-related adverse effects
- Growth monitoring
- Academic/behavioral monitoring
❤13👍12👏2